tiprankstipranks
Advertisement
Advertisement

BBIO Stock Latest News

BridgeBio rises 17.0%
The FlyBridgeBio rises 17.0%
22h ago
BBIO
BridgeBio Raises $934 Million via Preferred Equity Financing
PremiumCompany Announcements
BridgeBio Raises $934 Million via Preferred Equity Financing
8d ago
8K
BBIO
BridgeBio announces PROPEL 3 trial met primary endpoint
PremiumThe Fly
BridgeBio announces PROPEL 3 trial met primary endpoint
12d ago
BBIO
BridgeBio shareholders approve board changes and equity plan
PremiumCompany Announcements
BridgeBio shareholders approve board changes and equity plan
14d ago
8K
BBIO
3 Best Healthcare Stocks to Buy in June, According to Analysts
PremiumMarket News
3 Best Healthcare Stocks to Buy in June, According to Analysts
21d ago
ABT
BBIO
BridgeBio price target lowered to $96 from $106 at Mizuho
PremiumThe FlyBridgeBio price target lowered to $96 from $106 at Mizuho
24d ago
BBIO
Spruce Biosciences names Eric Jordan VP, marketing, Tina Gullotta VP, finance
Premium
The Fly
Spruce Biosciences names Eric Jordan VP, marketing, Tina Gullotta VP, finance
25d ago
BBIO
SPRB
Leidos, BridgeBio, T1 Energy, Ecopetrol, Medtronic Trending
Premium
Weekend Updates
Leidos, BridgeBio, T1 Energy, Ecopetrol, Medtronic Trending
1M ago
EC
TE
Yum! Brands upgraded, Chipotle downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Yum! Brands upgraded, Chipotle downgraded: Wall Street’s top analyst calls
1M ago
T
CAG
Canaccord starts BridgeBio on Attruby launch, pipeline
PremiumThe Fly
Canaccord starts BridgeBio on Attruby launch, pipeline
1M ago
BBIO
BridgeBio initiated with a Buy at Canaccord
PremiumThe Fly
BridgeBio initiated with a Buy at Canaccord
1M ago
BBIO
BridgeBio, Dave, Marvell, Filana, GE Trending With Analysts
PremiumWeekend Updates
BridgeBio, Dave, Marvell, Filana, GE Trending With Analysts
1M ago
GE
BBIO
BridgeBio price target raised to $98 from $94 at Morgan Stanley
PremiumThe FlyBridgeBio price target raised to $98 from $94 at Morgan Stanley
1M ago
BBIO
Analyst Lifts BridgeBio Price Target to $98 as BBP‑418 Becomes Core Growth Driver Following Strong Phase 3 Data
Premium
Ratings
Analyst Lifts BridgeBio Price Target to $98 as BBP‑418 Becomes Core Growth Driver Following Strong Phase 3 Data
1M ago
BBIO
BridgeBio Wins FDA Priority Review for BBP-418 Therapy
Premium
Company Announcements
BridgeBio Wins FDA Priority Review for BBP-418 Therapy
1M ago
8K
BBIO
BridgeBio announces FDA acceptance, priority review of BBP-418 NDA
PremiumThe Fly
BridgeBio announces FDA acceptance, priority review of BBP-418 NDA
1M ago
BBIO
Intel downgraded, Marvell upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Intel downgraded, Marvell upgraded: Wall Street’s top analyst calls
1M ago
CI
DT
Video: Eli Lilly rises after vaccine acquisitions
PremiumThe Fly
Video: Eli Lilly rises after vaccine acquisitions
1M ago
AZO
BAH
BridgeBio downgraded to Market Perform from Outperform at Raymond James
PremiumThe Fly
BridgeBio downgraded to Market Perform from Outperform at Raymond James
2M ago
BBIO
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
PremiumThe FlyStubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
2M ago
AMT
BAP
BridgeBio initiated with a Neutral at Citi
Premium
The Fly
BridgeBio initiated with a Neutral at Citi
2M ago
BBIO
BridgeBio Files FDA NDA for Encaleret in ADH1
Premium
Company Announcements
BridgeBio Files FDA NDA for Encaleret in ADH1
2M ago
8K
BBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >